Among IEIs, mutations in the interleukin-2-inducible T-cell kinase (ITK) gene are increasingly recognized as a cause of immune dysregulation with a heightened susceptibility to autoimmunity and malignancies. The gene discussed is ITK; the disease is Autoimmunity.